Queliza Karen, Ihekweazu Faith D, Ali Arshaan, Kellermayer Richard
Department of Pediatric Gastroenterology, Hepatology and Nutrition at Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA
Department of Pediatric Gastroenterology, Hepatology and Nutrition at Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
Ann Clin Lab Sci. 2017 Mar;47(2):226-228.
Concomitant inflammatory bowel disease (IBD) and immune thrombocytopenic purpura (ITP) is a rare phenomenon. A shared immunologic pathway leading to mucosal inflammation and platelet destruction has been proposed. We report a case of a 14-year-old male who presented with abdominal pain, hematochezia, weight loss, and thrombocytopenia. Endoscopic and hematologic evaluations led to the diagnosis of ulcerative colitis (UC) and ITP, respectively. Initial treatment of his UC resulted in improvement in both gastrointestinal symptoms and platelet count. Management of this case, however, was complicated by inconsistent correlation between UC symptoms and platelet count throughout his clinical course. The co-occurrence of IBD and ITP is an important entity, albeit rare, which needs to be considered when evaluating a patient with hematochezia and thrombocytopenia.
炎症性肠病(IBD)与免疫性血小板减少性紫癜(ITP)并存是一种罕见现象。有人提出了一条导致黏膜炎症和血小板破坏的共同免疫途径。我们报告一例14岁男性病例,该患者出现腹痛、便血、体重减轻和血小板减少。内镜和血液学评估分别诊断为溃疡性结肠炎(UC)和ITP。对其UC的初始治疗使胃肠道症状和血小板计数均得到改善。然而,在他的整个临床过程中,UC症状与血小板计数之间的相关性不一致,使该病例的管理变得复杂。IBD和ITP的并存是一个重要情况,尽管罕见,但在评估有便血和血小板减少的患者时需要考虑。